Cathie Wood acquired 7.18 Million Twist Bioscience shares worth $122 Million. That's 0.79% of their equity portfolio (25th largest holding). The investor owns 13.32% of the outstanding Twist Bioscience stock. The first Twist Bioscience trade was made in Q4 2019. Since then Cathie Wood bought shares ten more times and sold shares on three occasions. The investor's estimated purchase price is $471 Million, resulting in a loss of 74%.